Baculoviral IAP Repeat-Containing 7 (BIRC7) (C-Term) Peptide
BIRC7
Reactivity: Human
Host: Synthetic
BP, BI
Catalog No. ABIN5686064
Quick Overview for Baculoviral IAP Repeat-Containing 7 (BIRC7) (C-Term) Peptide (ABIN5686064)
Target
BIRC7
(Baculoviral IAP Repeat-Containing 7 (BIRC7))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), BioImaging (BI)
-
-
Protein Region
- C-Term
-
Characteristics
- BIRC7 peptide corresponds to 10 amino acids near the C-terminus region of BIRC7.
-
-
-
-
Application Notes
- BIRC7 Peptide is used for blocking the activity of BIRC7 antibody . The BIRC7 antibody ships at 0.5 mg/mL and the BIRC7 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- BIRC7 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
-
You are here:
